ASAHI INTECC CO. LTD.
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. It operates through the Medical and Device divisions. The company provides percutaneous coronary intervention (PCI) guide wires, guiding catheters, catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, … Read more
ASAHI INTECC CO. LTD. (6XT) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ASAHI INTECC CO. LTD. (6XT) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ASAHI INTECC CO. LTD. - Net Assets Trend (None–None)
This chart illustrates how ASAHI INTECC CO. LTD.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ASAHI INTECC CO. LTD. (None–None)
The table below shows the annual net assets of ASAHI INTECC CO. LTD. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ASAHI INTECC CO. LTD.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ASAHI INTECC CO. LTD. Competitors by Market Cap
The table below lists competitors of ASAHI INTECC CO. LTD. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yunnan Copper Co Ltd
SHE:000878
|
$3.49 Billion |
|
Sonae SGPS SA
LS:SON
|
$3.49 Billion |
|
Schroders PLC
PINK:SHNWF
|
$3.49 Billion |
|
Hyundai Mipo Dockyard
KO:010620
|
$3.49 Billion |
|
Fortune Electric Co Ltd
TW:1519
|
$3.49 Billion |
|
SpringWorks Therapeutics Inc
NASDAQ:SWTX
|
$3.48 Billion |
|
Mainfreight Limited
PINK:MFGHF
|
$3.48 Billion |
|
Copa Holdings SA
NYSE:CPA
|
$3.48 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ASAHI INTECC CO. LTD.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ASAHI INTECC CO. LTD.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ASAHI INTECC CO. LTD. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ASAHI INTECC CO. LTD.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ASAHI INTECC CO. LTD. (6XT) | €- | N/A | N/A | $3.49 Billion |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |